Exhibit 99.1

PSS World Medical Board of Directors Authorizes Purchase of 5% of
Total Common Shares

    JACKSONVILLE, Fla.--(BUSINESS WIRE)--June 8, 2004--PSS World
Medical, Inc. (NASDAQ/NM:PSSI) announced today that its Board of
Directors has authorized the purchase of up to 5% of its total common
shares.
    The Company is authorized from time to time, depending upon market
conditions and other factors, to repurchase up to a maximum of 5% of
its total common stock, or approximately 3.3 million common shares, in
the open market. Such repurchases will be made in compliance with
applicable rules and regulations and may be discontinued at any time.
As of April 2, 2004, the Company had approximately 68.0 million fully
diluted total common shares.
    All statements in this release that are not historical facts,
including, but not limited to, statements regarding anticipated growth
in revenue, gross and operating margins, and earnings, statements
regarding the Company's current business strategy, the Company's
ability to complete and integrate acquired businesses and generate
acceptable rates of return, the Company's projected sources and uses
of cash, and the Company's plans for future development and
operations, are based upon current expectations. Specifically,
forward-looking statements in this Press Release include, without
limitation, the Company's expected results in GAAP EPS, revenue,
operating incomes and operating margins for continuing operations and
discontinued operations for both the consolidated company and for each
of its businesses in fiscal year 2005; the expected operational cash
flow in fiscal year 2005; the ability to sustain revenue growth and
expected growth rates of the marketing programs in its Physician and
Elder Care Businesses; expected flu vaccine sales during fiscal year
2005; and expected sales growth from durable medical equipment,
housekeeping, revenues derived from home care and assisted living
customers, our expectations for revenue, operating income, operating
margin, cash flow from operations and earnings per share for fiscal
year 2005, as well as other expectations of growth and financial and
operational performance. These statements are forward looking in
nature and involve a number of risks and uncertainties. Actual results
may differ materially. Among the factors that could cause results to
differ materially are the following: pricing and customer credit
quality pressures; the loss of any of our distributorship agreements
and our reliance on relationships with our vendors; our reliance on a
limited number of elder care customers; the availability of sufficient
capital to finance the Company's business plans on terms satisfactory
to the Company; competitive factors; the ability of the Company to
adequately defend or reach a settlement of outstanding litigations and
investigations involving the Company or its management; changes in
labor, equipment and capital costs; changes in regulations affecting
the Company's business, such as the Medicare cliffs, changes in
malpractice insurance rates and tort reform; future acquisitions or
strategic partnerships; general business and economic conditions; and
other factors described from time to time in the Company's reports
filed with the Securities and Exchange Commission. Many of these
factors are outside the control of the Company. The Company wishes to
caution readers not to place undue reliance on any such forward
looking statements, which statements are made pursuant to the Private
Securities Litigation Reform Act of 1995 and, as such, speak only as
of the date made. The Company also wishes to caution readers that it
undertakes no duty or is under no obligation to update or revise any
forward-looking statements.

    CONTACT: PSS World Medical, Inc.
             Robert C. Weiner, 904-332-3287